Retinoic acid induces PGI synthase expression in human endothelial cells

Journal of Lipid Research

Volumn 49, Issue 8, 2008, Pages 1707-1714

  Camacho, Mercedes ^a   Rodríguez, Cristina ^a   Salazar, Juliana ^b   Martínez González, Jos ace ^a   Ribalta, Josep ^b   Escudero, José Román ^c   Masana, Lluís ^b   Vila, Luis ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b Institut Català de Ciències Cardiovasculars   (Spain)

^c UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

Cyclooxygenase pathway; Prostacyclin synthase; Prostaglandin I2; Retinoic acid receptor

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; CYCLOHEXIMIDE; DACTINOMYCIN; ISOTRETINOIN; PROSTACYCLIN SYNTHASE; RECOMBINANT INTERLEUKIN 1BETA; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOCHROME P450; ISOMERASE; PROSTACYCLIN;

ARACHIDONIC ACID METABOLISM; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN EXPRESSION; THROMBOCYTE AGGREGATION INHIBITION; TRANSCRIPTION REGULATION; UMBILICAL VEIN; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; DRUG EFFECT; ENZYME INDUCTION; ENZYMOLOGY; SECRETION; VASCULAR ENDOTHELIUM;

CELLS, CULTURED; CYCLOHEXIMIDE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOCHROME P-450 ENZYME SYSTEM; DACTINOMYCIN; ENDOTHELIUM, VASCULAR; ENZYME INDUCTION; EPOPROSTENOL; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; ISOTRETINOIN;

EID: 51449116606     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M700559-JLR200     Document Type: Article

References (53)

1. Vila, L. 2004. Cyclooxygenase and 5-lipoxygenase pathways in the vessel wall: role in atherosclerosis. Med. Res. Rev. 24: 399-424.
2. Bishop-Bailey, D., J. A. Mitchell, and T. D. Warner. 2006. COX-2 in cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 26: 956-958.
3. Martinez-Gonzalez, J., and L. Badimon. 2007. Mechanisms underlying the cardiovascular effects of Cox-inhibition: benefits and risks. Curr. Pharm. Des. 13: 2215-2227.
4. Ullrich, V., L. Castle, and P. Weber. 1981. Spectral evidence for the cytochrome P450 nature of prostacyclin synthase. Biochem. Pharmacol. 30: 2033-2036.
5. Zou, M. H., and V. Ullrich. 1996. Peroxynitrite formed by simultaneous generation of nitric oxide and superoxide selectively inhibits bovine aortic prostacyclin synthase. FEBS Lett. 382: 101-104.
6. Zou, M. H., C. Martin, and V. Ullrich. 1997. Tyrosine nitration as a mechanism of selective inactivation of prostacyclin synthase by peroxynitrite. Biol. Chem. 378: 707-713.
7. Wade, M. L., N. F. Voelkel, and F. A. Fitzpatrick. 1995. "Suicide" inactivation of prostaglandin I2 synthase: characterization of mechanism-based inactivation with isolated enzyme and endothelial cells. Arch. Biochem. Biophys. 321: 453-458.
8. Camacho, M., J. López-Belmonte, and L. Vila. 1998. Rate of vasoconstrictor prostanoids released by endothelial cells depends on cyclooxygenase-2 expression and PGI-synthase activity. Circ. Res. 83: 353-365.
9. Camacho, M., and L. Vila. 2000. Transcellular formation of thromboxane A2 in mixed incubations of endothelial cells and aspirintreated platelets strongly depends on the prostaglandin I-synthase activity. Thromb. Res. 99: 155-164.
10. Soler, M., M. Camacho, A. M. Molins-Pujol, and L. Vila. 2001. Effect of an imidazolineoxyl N-oxide on prostaglandin synthesis in experimental shock: possible role of nitrogen dioxide in prostacyclinsynthase inactivation. J. Infect. Dis. 183: 105-112.
11. Soler, M., M. Camacho, J. R. Escudero, M. A. Iñiguez, and L. Vila. 2000. Human vascular smooth muscle cells but not endothelial cells express prostaglandin E synthase. Circ. Res. 87: 504-507.
12. McAdam, B. F., F. Castella-Lawson, I. A. Mardini, S. Kapoor, J. A. Lawson, and G. A. Fitzgerald. 1999. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. Proc. Natl. Acad. Sci. USA. 96: 272-277.
13. Camacho, M., E. Gerbolés, J. R. Escudero, R. Antón, X. García-Moll, and L. Vila. 2007. Microsomal-PGE synthase-1, which is not coupled to a particular COX-isoenzyme, is essential for PGE2 biosynthesis in vascular smooth muscle cells. J. Thromb. Haemost. 5: 141-1419.
14. De Luca, L. M. 1991. Retinoids and their receptors in differentiation, embryogenesis, and neoplasia. FASEB J. 5: 2924-2933.
15. Muindi, J. R., S. R. Frankel, C. Huselton, F. DeGrazia, W. A. Garland, C. W. Young, and R. P. Warrell. 1992. Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. Cancer Res. 52: 2138-2142.
16. Thacher, S. M., J. Vasudevan, and R. A. Chandraratna. 2000. Therapeutic applications for ligands of retinoid receptor. Curr. Pharm. Des. 6: 25-58.
17. Achan, V., C. T. L. Tran, F. Arrigoni, G. S. J. Whitley, J. M. Leiper, and P. Vallance. 2002. All-trans-retinoic acid increases nitric oxide synthesis by endothelial cells. Circ. Res. 90: 764-769.
18. Marchetti, M., A. Vignoli, M. R. Bani, D. Balducci, T. Barbui, and A. Falanga. 2003. All-trans retinoic acid modulates microvascular endothelial cell hemostatic properties. Haematologica. 88: 895-905.
19. Yokota, J., M. Kawana, C. Hidai, Y. Aoka, K. Ichikawa, N. Iguchi, M. Okada, and H. Kasanuki. 2001. Retinoic acid suppresses endothelin-1 gene expression at the transcription level in endothelial cells. Atherosclerosis. 159: 491-496.
20. Haxsen, V., S. Adam-Stitah, E. Ritz, and J. Wagner. 2001. Retinoids inhibit the actions of angiotensin II on vascular smooth muscle cells. Circ. Res. 88: 637-644.
21. Uruno, A., A. Sugawara, M. Kudo, M. Sato, K. Sato, S. Ito, and K. Takeuchi. 2003. Transcription suppression of thromboxane receptor gene expression by retinoids in vascular smooth muscle cells. Hypertens. Res. 26: 815-821.
22. Barstad, M. B., M. J. A. G. Hamers, R. W. Stephens, and K. J. Sakariassen. 1995. Retinoic acid reduces induction of monocyte tissue factor and tissue factor/factor VIIa dependent arterial thrombus formation. Blood. 86: 212-218.
23. Varani, J., J. Jones, M. Dame, C. Sulavik, D. F. Gibbs, and K. J. Johnson. 1991. Effects of all-trans-retinoic acid on neutrophilmediated endothelial cell injury in vitro and immune complex injury in rats. Am. J. Pathol. 139: 901-909.
24. Shaish, A., A. Daugherty, F. O'Sullivan, G. Schonfeld, and J. W. Heinecke. 1995. Betacarotene inhibits atherosclerosis in hypercholesterolemic rabbits. J. Clin. Invest. 96: 2075-2082.
25. Miano, J. M., L. A. Kelly, C. A. Artacho, T. A. Nuckolls, R. Piantedosi, and W. S. Blaner. 1998. All-trans-retinoic acid reduces neointimal formation and promotes favorable geometric remodeling of the rat carotid artery balloon withdrawal injury. Circulation. 98: 1219-1227.
26. Neuville, P., Z. Yan, A. Gidlof, M. S. Pepper, G. K. Hansson, G. Gabbiani, and A. Sirsjo. 1999. Retinoic acid regulates arterial smooth muscle cell proliferation and phenotypic features in vivo and in vitro through an RARα-dependent signaling pathway. Arterioscler. Thromb. Vasc. Biol. 19: 1430-1436.
27. DeRose, J. J., J. Madigan, J. P. Umama, J. H. Prystowsky, R. Nowygrod, M. C. Oz, and G. J. Todd. 1999. Retinoic acid suppresses intimal hyperplasia and prevents vessel remodeling following arterial injury. Cardiovasc. Surg. 7: 633-639.
28. Wiegman, P. J., W. L. Barry, J. A. McPherson, C. A. McNamara, L. W. Gimple, J. M. Sanders, G. G. Bishop, E. R. Powers, M. Ragosta, G. K. Owens, et al. 2000. All-trans-retinoic acid limits restenosis after balloon angioplasty in the focally atherosclerotis rabbit: a favorable effect on vessel remodeling. Arterioscler. Thromb. Vasc. Biol. 20: 89-95.
29. Leville, C. D., M. S. Dassow, G. R. Seabrook, J. M. Jean-Claude, J. B. Towne, and R. A. Cambria. 2000. All-trans-retinoic acid decreases vein graft intimal hyperplasia, and matrix metalloproteinase activity in vivo. J. Surg. Res. 90: 183-190.
30. Lee, C. W., S. J. Park, S. W. Park, J. J. Kim, M. K. Hong, and J. K. Song. 2000. All-trans-retinoic acid attenuates neointima formation with acceleration of reendothelization in ballon-injured rat aorta. J. Korean Med. Sci. 15: 31-36.
31. Herdeg, C., M. Oberhoff, A. Baumbach, S. Schroeder, M. Leitritz, A. Blattner, D. I. Siegel-Axel, C. Meisner, and K. R. Karsch. 2003. Effects of local all-trans-retinoic acid delivery on experimental atherosclerosis in the rabbit carotid artery. Cardiovasc. Res. 57: 544-553.
32. Lee, J. Y. Y., C. P. Mak, B-J. Wang, and W. C. Chang. 1992. Effects of retinoids on endothelial cell proliferation, prostacyclin production and platelet aggregation. J. Dermatol. Sci. 3: 157-162.
33. Spencer-Green, G. 1994. Retinoic acid effects on endothelial cell function: interaction with interleukin 1. Clin. Immunol. Immunopathol. 72: 53-61.
34. Camacho, M., N. Godessart, R. Antón, M. García, and L. Vila. 1995. Interleukin-1 enhances the ability of cultured umbilical vein endothelial cells to oxidize linoleic acid. J. Biol. Chem. 270: 17279-17286.
35. Umemiya, H., H. Fukasawa, M. Ebisawa, L. Eyrolles, E. Kawachi, G. Eisenmann, H. Gronemeyer, Y. Hashimoto, K. Shudo, and H. Kagechika. 1997. Regulation of retinoidal actions by diazepinylbenzoic acids. Retinoid synergists which activate the RXR-RAR heterodimers. J. Med. Chem. 40: 4222-4234.
36. Takahashi, B., K. Ohta, E. Kawachi, H. Fukasawa, Y. Hashimoto, and H. Kagechika. 2002. Novel retinoid X receptor antagonists: specific inhibition of retinoid synergism in RXR-RAR heterodimer actions. J. Med. Chem. 45: 3327-3330.
37. Saito, A., A. Sugawara, A. Uruno, M. Kudo, H. Kagechika, Y. Sato, Y. Owada, H. Kondo, M. Sato, M. Kurabayashi, et al. 2007. Alltrans retinoic acid induces in vitro angiogenesis via retinoic acid receptor: possible involvement of paracrine effects of endogenous vascular endothelial growth factor signaling. Endocrinology. 148: 1412-1423.
38. Iwata, M., Y. Eshima, and H. Kagechika. 2003. Retinoic acids exert direct effects on T cells to suppress Th1 development and enhance Th2 development via retinoic acid receptors. Int. Immunol. 15: 1017-1025.
39. Solá, J., N. Godessart, L. Vila, L. Puig, and J. M. de Moragas. 1992. Epidermal cell-polymorphonuclear leukocyte cooperation in the formation of leukotriene B4 by transcellular biosynthesis. J. Invest. Dermatol. 98: 333-339.
40. Raposo, B., C. Rodríguez, J. Martínez-González, and L. Badimon. 2004. High levels of homocysteine inhibit lysyl oxidase (LOX) and downregulate LOX expression in vascular endothelial cells. Atherosclerosis. 177: 1-8.
41. Vila, L., C. Cullaré, J. Solá, L. Puig, C. de Castellarnau, and J. M. de Moragas. 1991. Cyclooxygenase activity is increased in platelets from psoriatic patients. J. Invest. Dermatol. 97: 922-926.
42. Vila, L., C. Cullaré, C. de Castellarnau, C. Gibert, and J. García. 1988. In vitro response of prostacyclin-treated platelets frozen with dimethylsulfoxide to pairs of aggregating agents. Cryo Letters. 9: 266-273.
43. Colbert, M. C., D. G. Hall, T. R. Kimball, S. A. Witt, J. N. Lorenz, M. L. Kirby, T. E. Hewett, R. Klevitsky, and J. Robbins. 1997. Cardiac compartment-specific overexpression of a modified retinoic acid receptor produces dilated cardiomyopathy and congestive heart failure in transgenic mice. J. Clin. Invest. 100: 1958-1968.
44. Lansik, M., P. Koolwijk, V. van-Hinsbergh, and T. Kooistra. 1998. Effect of steroid hormones and retinoids on the formation of capillary-like tubular structures of human microvascular endothelial cells in fibrin matrices is related to urokinase expression. Blood. 92: 927-938.
45. Soler, M., M. Camacho, and L. Vila. 2003. Imidazolineoxyl Noxide prevents the impairment of vascular contraction caused by interleukin-1b through several mechanisms. J. Infect. Dis. 188: 927-937.
46. Rius, J., J. Martinez-Gonzalez, J. Crespo, and L. Badimon. 2006. NOR-1 is involved in VEGF-induced endothelial cell growth. Atherosclerosis. 184: 276-282.
47. Schug, T. T., D. C. Berry, N. S. Shaw, S. N. Travis, and N. Noy. 2007. Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors. Cell. 129: 723-733.
48. Brandebourg, T. D., and C. Y. Hu. 2005. Regulation of differentiating pig preadipocytes by retinoic acid. J. Anim. Sci. 83: 98-107.
49. Shinozaki, Y., Y. Sato, S. Koizumi, Y. Ohno, T. Nagao, and K. Inoue. 2007. Retinoic acids acting through retinoid receptors protect hippocampal neurons from oxygen-glucose deprivation-mediated cell death by inhibition of c-jun-N-terminal kinase and p38 mitogenactivated protein kinase. Neuroscience. 147: 153-163.
50. He, J. C., T. C. Lu, M. Fleet, M. Sunamoto, M. Husain, W. Fang, S. Neves, Y. Chen, S. Shankland, R. Iyengar, et al. 2007. Retinoic acid inhibits HIV-1-induced podocyte proliferation through the cAMP pathway. J. Am. Soc. Nephrol. 18: 93-102.
51. Gillespie, R. F., and L. J. Gudas. 2007. Retinoid regulated association of transcriptional co-regulators and the polycomb group protein SUZ12 with the retinoic acid response elements of Hoxa1, RARbeta(2), and Cyp26A1 in F9 embryonal carcinoma cells. J. Mol. Biol. 372: 298-316.
52. Wang, J., and A. Yen. 2004. A novel retinoic acid-responsive element regulates retinoic acid-induced BLR1 expression. Mol. Cell. Biol. 24: 2423-2443.
53. Keith, R. L., Y. E. Miller, Y. Hoshikawa, M. D. Moore, T. L. Gesell, B. Gao, A. M. Malkinson, H. A. Golpon, R. A. Nemenoff, and M. W. Geraci. 2002. Manipulation of pulmonary prostacyclin synthase expression prevents murine lung cancer. Cancer Res. 62: 734-740.